Brief: China Medical System Announces Establishment Of JV By Rxilient And Junshi Biosciences

China Medical System Holdings

28/03/2023 11:37

March 28 (Reuters) - China Medical System Holdings Ltd
 0867.HK :
    * ESTABLISHMENT OF JOINT VENTURE BY RXILIENT AND JUNSHI
BIOSCIENCES
    * JUNSHI BIOSCIENCES WILL SUBSCRIBE FOR SHARES NEWLY ISSUED
BY
EXCELLMAB IN NON-MONETARY MANNER TO OBTAIN 40% STAKE
    * RXILIENT BIOTECH WILL SUBSCRIBE FOR NEWLY ISSUED SHARES OF
EXCELLMAB FOR $5.0 MILLION
    * UPON AGREEMENT COMPLETION, EXCELLMAB WILL BE OWNED AS TO
60% BY
RXILIENT BIOTECH AND 40% BY JUNSHI BIOSCIENCES
    * JUNSHI BIOSCIENCES TO ENTER AGREEMENT WITH EXCELLMAB TO
GRANT
EXCLUSIVE LICENSE TO COMMERCIALIZE INTRAVENOUS TORIPALIMAB

Source text for Eikon:  ID:nHKS4lg4YQ 
Further company coverage:  0867.HK